Allianz Asset Management
KYTH

Allianz Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Allianz Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-119,475
Closed -$8.96M – 2604
2015
Q3 		$8.96M Buy
119,475
+77,875
+187% +$5.82M 0.01% 1029
2015
Q2 		$3.13M Sell
41,600
-171,740
-81% -$9.2M ﹤0.01% 1535
2015
Q1 		$10.7M Hold
213,340
– – 0.01% 930
2014
Q4 		$7.4M Buy
213,340
+106,670
+100% +$3.72M 0.01% 1074
2014
Q3 		$3.5M Hold
106,670
– – ﹤0.01% 1223
2014
Q2 		$4.09M Sell
106,670
-11,015
-9% -$385K 0.01% 990
2014
Q1 		$4.68M Hold
117,685
– – 0.01% 971
2013
Q4 		$4.4M Hold
117,685
– – 0.01% 986
2013
Q3 		$5.37M Hold
117,685
– – 0.01% 898
2013
Q2 		$3.18M Buy
+117,685
New +$2.69M ﹤0.01% 1048

Allianz Asset Management's KYTH Position: Q4 2015 in Review

Allianz Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 119,475 shares — an estimated $8.96M sold.

Allianz Asset Management first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $10.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Allianz Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Allianz Asset Management sold 119,475 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $8.96M.
  • Allianz Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Allianz Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $10.7M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Allianz Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.